Previous close | 26.82 |
Open | 27.02 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 27.02 - 27.94 |
52-week range | 27.02 - 63.24 |
Volume | |
Avg. volume | 574 |
Market cap | N/A |
Beta (5Y monthly) | 1.89 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.80 |
Earnings date | 30 Apr 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Here are three stocks, TXG, CAH and HOLX, which are expected to beat earnings estimates in the ongoing reporting cycle.
In this piece, we will take a look at the 11 oversold midcap stocks to buy now. If you want to skip our coverage of overbought, oversold, small cap, and mid cap stocks along with the latest stock market news, then you can skip ahead to the 5 Oversold MidCap Stocks To Buy Now. Since […]
10x Genomics (TXG) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.